Clinical trial
Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
NCT00031759 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00031759 |
|---|---|
| Title | Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia |
| Official title | Phase II Topical Immunomodulatory Therapy With Imiquimod for the Chemoprevention of Recurrent and High-Grade Cervical Intraepithelial Neoplasia (CIN) |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Precancerous Condition |
| Intervention type | Drug, Procedure |
| Interventions | imiquimod, Ablative or excisional therapy |
| Enrollment | 57 |
| Start date | Jun 1, 1999 |
| Primary completion | Jul 1, 2004 |
| Completion | Feb 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 13, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: